# Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling

> **NCT00556244** · PHASE1,PHASE2 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Patients With Proliferative Diabetic Retinopathy Who Have Active Fibrovascular Proliferation

## Interventions

- **PROCEDURE:** ILM peeling

## Key facts

- **NCT ID:** NCT00556244
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2007-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556244, "Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00556244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*